Stephen Rooke

Stephen Rooke serves as Chief Technology Officer at Healthxchange Group. Healthxchange Group operates in the pharmaceuticals sector with approximately 140.0 employees. The company is headquartered in Barnet, England. Healthxchange Group generates annual revenue of 35000000.0.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • We have verified contacts for 2 executives at Healthxchange Group.
• • 10,137 executive contacts are available in England.
• • Our database includes 201,469 c suite-level executives.

DNS Made Easy Outlook MailChimp SPF Microsoft Office 365 Angular JS v1 Salesforce Emarsys Bing Ads Facebook Custom Audiences Ruby On Rails Typekit Google AdWords Conversion Nginx Facebook Login (Connect) Hotjar DoubleClick Google Dynamic Remarketing Facebook Widget Google Tag Manager Google Font API Google Maps (Non Paid Users) DoubleClick Conversion Mobile Friendly Vimeo Bootstrap Framework AngularJS Google Maps

fast accurate & competitively priced quality aesthetic supplies botox obagi intracel aqualyx dr levy aesthetic supplies dermal fillers aesthetics pharmaceutical manufacturing aesthetic pharmacy cosmetic products medical aesthetic supplies skin treatments botulinum treatments skin resurfacing injectables patient management clever clinic clever patients obagi medical products topical skin solutions pharmacovigilance patient safety skin care acne treatments hyperpigmentation solutions anti-aging products surgical aesthetic solutions medical devices skincare innovations training for clinics clinic finder order management fast delivery quality brands minimally invasive treatments cosmetic injectables skin health education acne scars treatment beauty products health & wellbeing medical-grade products injectable training patient support tools skin care consultation sustainable practices cosmetics education cosmetic pharmacy supplies advanced skin care technology cosmetic pharmacy solutions facial rejuvenation patient experience enhancement clinical aesthetics beauty supply distributor professional skincare medical supply chain pharmaceuticals medical hospital & health care

JC

Jack Curran Chief Executive Officer at Healthxchange Group

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

Outreach Guidance — pharmaceuticals Sector

Executives like Stephen Rooke in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Healthxchange Group.

How do I reach Stephen Rooke directly?

Stephen Rooke's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at Healthxchange Group. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Stephen Rooke work for?

Stephen Rooke is Chief Technology Officer at Healthxchange Group, a company in the pharmaceuticals sector with 140.0 employees. The company is based in Barnet, England.

Can I pitch or sell to Stephen Rooke?

As Chief Technology Officer at Healthxchange Group, Stephen Rooke is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Stephen Rooke directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Stephen Rooke in?

Stephen Rooke works in the pharmaceuticals industry as Chief Technology Officer at Healthxchange Group. MessageCEO provides verified contact information for executives across all major industries.

Is Stephen Rooke's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Stephen Rooke's profile is kept up-to-date with the latest available information.

Last updated: May 11, 2026